Home › Relapsing-Remitting Multiple Sclerosis › Illinois
Relapsing-Remitting Multiple Sclerosis clinical trials in Illinois
6 studies for Relapsing-Remitting Multiple Sclerosis are looking for participants at sites in Illinois.
Cities in Illinois
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
- Northwestern University, Evanston
RecruitingPhase 3
Ages 18 to 55 · All sexes · Updated Sep 16, 2026 · NCT04047628Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis
- University of Chicago Medical Center, Chicago
RecruitingPhase 3
Ages 10 to 17 · All sexes · Updated Sep 10, 2026 · NCT06408259Intermittent Hypoxia in Persons With Multiple Sclerosis
- Shirley Ryan AbilityLab, Chicago
Recruiting
Ages 18 to 75 · All sexes · Updated Mar 20, 2026 · NCT06276634Ublituximab (Briumvi) for Early Forms of Relapsing Multiple Sclerosis
- Northwestern Memorial Hospital, Chicago
RecruitingPhase 4
Ages 18 to 70 · All sexes · Updated Mar 17, 2026 · NCT07225361Effects of Acute Intermittent Hypoxia on Neuroplasticity in MS
- Shirley Ryan AbilityLab, Chicago
Recruiting
Ages 18 to 75 · All sexes · Updated Feb 23, 2026 · NCT06390930Home Based Functional Balance Intervention for Multiple Sclerosis
- University of Illinois at Chicago, Chicago
Recruiting
Ages 40 to 90 · All sexes · Updated Jan 21, 2026 · NCT07355387From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.